SGC-CBP30
SGC-CBP30 is a potent and selective inhibitor of CREBBP (CBP) and EP300; which are general transcriptional co-activators. CREBBP has also been associated with Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig ’s disease, a neurodegenerative disease with progressive degeneration of motor neurons in the brain and spinal cord, Alzheimer's disease and poly glutamine repeat diseases such as Spinal and Bulbar Muscular Atrophy and Huntington ’s disease.
Product Specifications
CAS Number
1613695-14-9
Product Name Alternative
SGC-CBP30 | SGC-CBP 30 | SGC-CBP-30
Field of Research
Immunology & Inflammation
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 31 mg/mL; 60.90 mM
Smiles
Cc1noc (C) c1c1cc2nc (CCc3ccc (OC) c (Cl) c3) n (C[C@H] (C) N3CCOCC3) c2cc1
Molecular Formula
C28H33CIN4O3
Molecular Weight
509.04
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(S) -4- (1- (2- (3-chloro-4-methoxyphenethyl) -5- (3,5-dimethylisoxazol-4-yl) -1H-benzo[d]imidazol-1-yl) propan-2-yl) morpholine
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
alpha 1b Adrenergic Receptor (ADRA1B) Goat Polyclonal Antibody
Synphilin-1 Polyclonal Antibody, PerCP Conjugated
Lentiviral human SLC12A5 shRNA (UAS) - Lentiviral human SLC12A5 shRNA (UAS, RFP) (100)
